Replies to post #247599 on Biotech Values

[DewDiligence]

LLY-DICE PR:

https://investor.lilly.com/news-releases/news-release-details/lilly-acquire-dice-therapeutics-advance-innovation-immunology

The $48/sh buyout price is a 42% premium to DICE’s closing price on 6/16/23 (coincidentally the same buyout premium that PFE is paying for SGEN). The nominal deal value is $2.4B.